Linifanib versus sorafenib in patients with advanced hepatocellular carcinoma: Results of a randomized phase III trial

Additional Metadata
Persistent URL	doi.org/10.1200/JCO.2013.54.3298, hdl.handle.net/1765/85643
Journal	Journal of Clinical Oncology
Organisation	Erasmus MC Cancer Institute
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Cainap, C, Qin, S, Huang, W.-T, Chung, I.J, Pan, H, Cheng, Y, … El-Nowiem, S. (2015). Linifanib versus sorafenib in patients with advanced hepatocellular carcinoma: Results of a randomized phase III trial. Journal of Clinical Oncology, 33(2), 172–179. doi:10.1200/JCO.2013.54.3298

Publication